http://www.xconomy.com/seattle/2009/05/11/proteotech-raises-519k/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/seattle/2009/05/11/proteotech-raises-519k/comment-page-1/#comment-57396 Today’s Financings, Deals and Venture Updates… | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky Tue, 12 May 2009 01:24:57 +0000 http://www.xconomy.com/?p=24222#comment-57396 [...] Finally, ProteoTech, a company we also profiled some time ago, said it has raised $519K in a debt offering, according to Xconomy. ProtetoTech is developing Exebryl-1, a component of Cat’s Claw, for mild to moderate Alzheimer’s disease. The company also has an earlier stage drug in development for Parkinson’s disease which is funded by the Michael J. Fox Foundation. [Xconomy] [...] [...] Finally, ProteoTech, a company we also profiled some time ago, said it has raised $519K in a debt offering, according to Xconomy. ProtetoTech is developing Exebryl-1, a component of Cat’s Claw, for mild to moderate Alzheimer’s disease. The company also has an earlier stage drug in development for Parkinson’s disease which is funded by the Michael J. Fox Foundation. [Xconomy] [...]

]]>